RealReal (REAL) reported a narrower Q3 adjusted loss late Monday, outpacing estimates, and grew revenue more than forecast. The company's guidance for full-year 2025 sales also beat market expectations.
Shares surged 35% as intraday trading volume advanced to more than 15.3 million from a daily average of about 3.8 million.
Surmodics (SRDX) shares soared 49% after the company said Tuesday the US District Court for the Northern District of Illinois denied a request by the Federal Trade Commission and certain state regulators for a preliminary injunction that would have blocked its proposed acquisition by a GTCR affiliate.
More than 2.2 million shares of the company traded intraday compared with a daily average of about 175,000.
Guardian Pharmacy Services (GRDN) swung to the black in Q3 earnings and also raised its full-year 2025 sales forecast.
Shares jumped past 8%, with intraday trading volume at over 702,400 compared with a daily average of about 349,000.
Comments